Elephant endotheliotropic herpesvirus-hemorrhagic disease (EEHV-HD) is an acute fatal disease in elephants. Despite the fact that the underlying pathogenesis of EEHV-HD has been proposed, it remains undetermined as to what mechanisms drive these hemorrhagic and edematous lesions. In the present study, we have investigated and explained the pathogenesis of acute EEHV-HD using blood profiles of EEHV-HD and EEHV-infected cases, hematoxylin and eosin (H&E) stain, special stains, immunohistochemistry, quantitative polymerase chain reaction (PCR) and reverse transcriptase polymerase chain reaction (RT-PCR). It was found that EEHV genomes were predominantly detected in various internal organs of EEHV-HD cases. Damage to endothelial cells, vasculitis and vascular thrombosis of the small blood vessels were also predominantly observed. Increases in platelet endothelial cell adhesion molecules-1 (PECAM-1)- and von Willebrand factor (vWF)-immunolabeling positive cells were significantly noticed in injured blood vessels. The expression of pro-inflammatory cytokine mRNA was significantly up-regulated in EEHV-HD cases when compared to EEHV-negative controls. We have hypothesized that this could be attributed to the systemic inflammation and disruption of small blood vessels, followed by the disseminated intravascular coagulopathy that enhanced hemorrhagic and edematous lesions in EEHV-HD cases. Our findings have brought attention to the potential application of effective preventive and therapeutic protocols to treat EEHV infection in Asian elephants.
Elephant endotheliotropic herpesvirus-hemorrhagic disease (EEHV-HD) is the most consequential viral infectious disease in young Asian elephants (Elephas maximus)1,2,3. Elephant calves that have died due to EEHV-HD displayed one or more of the following clinical signs: fever, lethargy, bloody diarrhea, facial edema or a cyanotic tongue1, 3, 4. Hematological evaluation of EEHV-HD calves is usually diagnosed by the emergence of anemia, thrombocytopenia, monocytopenia and/or a reduction in plasma protein concentration1, 5. Gross and microscopic findings can reveal generalized hemorrhages and edema of the subcutaneous, subserosa and certain internal organs including the heart, lungs, liver, spleen, kidneys, lymph nodes and intestines2, 4. To date, despite the fact that the mechanisms of hemorrhages and edema in EEHV-HD cases have been hypothesized6,7,8, to the best of our knowledge no such studies have investigated the pathogenesis underlying of those pathological lesions. In fact, the pathogenesis of hemorrhages, thrombocytopenia and protein leaks emitted from blood vessels during acute fatal EEHV infection are still far from being fully understood.
Mechanisms of virus-induced plasma leakage emitted from blood vessels can be due to either direct lytic endothelial cell infection or induction of physiological mechanisms that increase vascular permeability9. An increase in vascular permeability is often initiated in response to various cellular mediators that are secreted by the endothelia, leukocytes or perivascular mast cells10. On the other hand, damage to the endothelia is known to increase the expression of certain glycoproteins, such as the von Willebrand factor (vWF) and platelet endothelial cell adhesion molecules (PECAM), on the endothelia and platelets that are known to promote cell-endothelial adhesion and platelet activation11, 12. The acquisition of the latter may eventually cause over consumption of platelets which can then lead to disseminated intravascular coagulation (DIC). This will potentially cause irreversible vascular damage and likely result in organ dysfunction or hypovolemic shock13, 14.
During viral infections, platelet activation is triggered by viruses and can modulate the number of platelets by decreasing platelet production, increasing platelet consumption or increasing platelet destruction15, 16. All of which would depend upon the specific viral species in question. In fact, it can be stated that during the viremia phase of some virus infections, an enhancement in platelet consumption is observed as a form of virus-induced DIC16, 17. This would be especially true for illnesses associated with viral hemorrhagic fevers such as Dengue hemorrhagic fever, Chikungunya, Ebola, Marburg hemorrhagic fever and Lassa fever16. Meanwhile, an increase in platelet destruction was predominantly observed in certain virus-induced immune mediated diseases such as human immunodeficiency virus (HIV)-118. On the other hand, an increase in vascular permeability by perivascular mast cells is shown to be one of the mechanisms that can induce vascular leakage in cases of Dengue hemorrhagic fever19,20,21. In elephants, it remains undetermined as to whether EEHV infection can induce vascular hyperpermeability. However, it cannot be ruled out since some elephant calves that have died as a result of acute EEHV-HD showed only a mild to moderate degree of vascular inflammation6. Moreover, it is of significant interest to demonstrate how EEHV infection is associated with injuries of the blood vessels and thrombocytopenia in EEHV-HD cases, which subsequently can result in bleeding disorders and may lead to severe multifocal hemorrhagic lesions in EEHV-HD calves. In the present study, we seek to investigate whether and how endothelial lesions, through the activation of platelets and the expression of cytokine, play a role in the pathomechanisms of hemorrhagic disease caused by EEHV in Asian elephants.
Thrombocytopenia is a predictive hematological parameter for acute fatal EEHV-HD
The archival records of fatal EEHV-HD and non-fatal EEHV-infected elephant blood samples submitted to the Veterinary Diagnostic Center, Chiang Mai University between the years of 2015 and 2020 clearly indicate that thrombocytopenia was the only significant hematological parameter observed in acute fatal EEHV-HD cases when compared to either the reference values (Table 1) or the EEHV-negative controls (Table S1). This was especially true for animals aged less than 5 years old. It should be noted that despite the fact that a reduction in the platelet count was observed in fatal EEHV-HD subjects, other hematological parameters, including red blood cell counts, pack cell volume (PCV) or plasma proteins, were included in the normal reference values (Table 1).
Blood monitoring of the EEHV1A-HD, EEHV4-HD and EEHV1A/4-HD cases indicate that a marked reduction in the platelet counts in elephant blood circulation could be an indicative factor of acute death since the platelet count in most of the fatal EEHV-HD cases dropped within 24 h prior the subject passing (Table 2).
Histopathological analysis of vascular lesions in fatal EEHV-HD and EEHV-negative calves
The grading of vascular lesions in elephant tissues using H&E stain indicated that the heart, kidneys, lungs, spleen and intestines, of deceased EEHV-HD calves had a significantly greater amount of severe vascular lesions when compared to the EEHV-negative controls (Fig. 1A). The vascular lesion scores in the EEHV-HD cases were correlated with the high viral genome copies that were found in various internal organs including the heart, kidneys, lungs, spleen and intestines (Table S2). However, despite the fact that EEHV genomes were detected at a high value, the vascular lesions in the liver were not found to be significantly different (Fig. 1A and Table S2). It has been noted that blood vessels that show significant pathological lesions were typically limited to small arteries, arterioles, capillaries and venules (Fig. 1B). In this case, these histopathological lesions ranged from mild to severe in terms of the fibrinonecrotizing or lymphohistiocytic arteritis or lymphangitis/phlebitis with various degrees of hemorrhaging (Fig. S1). Perivascular tissues were also found to have expanded in relation to the edema and infiltrating inflammatory cells (Fig. S1). The periodic acid-Schiff (PAS) stain revealed disruption of the endothelia and basement membrane of the EEHV-HD small blood vessels of the visceral organs (Fig. 1C). However, blood vessels in the central nervous system (CNS), including the brain and spinal cord, were found to be unaltered when compared to the EEHV-negative controls (Fig. 1C). Medium and large blood vessels were observed to show a limited degree of inflammation in the vasa vasorum of the tunica adventitia and media (Fig. S1). These findings suggest that small blood vessels, rather than large blood vessels, are damaged during acute fatal EEHV-HD.
Thromboemboli in blood vessels of fatal EEHV-HD cases
Phosphotungstic acid hematoxylin (PTAH) stain demonstrated that fibrin formation was predominantly observed as thromboemboli in the blood vessels or extravascular space of the internal organs including the lungs, heart, kidneys and intestines of EEHV1A-HD, EEHV4-HD and EEHV1A/4-HD calves (Fig. 2).
Mast cells are less likely to increase vascular permeability in acute fatal EEHV-HD
Since degranulation of mast cells plays a central role in the increase of vascular permeability in several diseases caused by viruses21, 23, 24, this study investigated whether this mechanism typically occurs in EEHV-HD cases. Our results indicate that neither proliferation nor degranulation of perivascular mast cells was different in comparisons made between fatal EEHV-HD cases and the EEHV-negative controls (Fig. 3).
Increase of PECAM-1-immunolabeling positive cells in EEHV-HD cases
Since PECAM-1 expression was determined to be a marker for activated endothelia and could be used to determine adhesion of platelets or leukocytes to damaged endothelia25, immunohistochemistry (IHC) for PECAM-1 was performed in this study. The results indicated that PECAM-1 positive cells were shown to be significantly observed in EEHV-HD cases when compared to the EEHV-negative controls (Fig. 4). However, it should be noted that the degree of PECAM-1 expression was found to be different in different organs of EEHV1A-HD, EEHV4-HD and EEHV1A/4-HD cases (Fig. 4A).
Increase of von Willebrand factor (vWF)-immunolabeling positive cells in EEHV-HD cases
IHC for the detection of vWF antigens revealed that positive cells were significantly observed in the heart, lungs and intestines of the EEHV1A-HD and EEHV4-HD cases, while the expression of vWF in the kidneys, spleen and liver was found to be non-significantly different when compared to the EEHV-negative controls (Fig. 5A). Importantly, not only was vascular endothelia expressed in the vWF antigens, but leukocytes that adhered to the endothelia were also stained by the vWF antibody (Fig. 5B).
Up-regulation of cytokine mRNA in tissue samples of EEHV-HD calves
Quantification of cytokine mRNA expression in EEHV1A-HD tissues indicated a significant degree of up-regulation of IL-1β, IL-4, TNF-α and IFN-γ expression in the heart, while the liver and lungs showed a significant degree in mRNA up-regulation of IL-2, IL-4, IL-8 and IL-2, TNF-α and IFN-γ expression, respectively (Fig. 6). Meanwhile, samples of the heart, liver and lungs of the EEHV4-HD cases also revealed a significant degree of up-regulation of several cytokines, including IL-1β, IL-2, IL-4, IL-8, TNF-α and IFN-ɣ, when compared to the un-related EEHV-infected cases (Fig. 6).
In this study, we have demonstrated and proposed that massive endothelial destruction and systemic inflammation caused by EEHV dysregulated blood coagulation systems resulting in severe hemorrhaging and edema. EEHV in elephants is disseminated throughout the body via the circulation of EEHV-infected blood monocytes6. In small blood vessels or microvessels, EEHV was transmitted from virus-infected monocytes to the endothelia by adhesion of monocytes to specific molecules present in the endothelia. This would then allow the endothelia to be infected and to serve as replication sites for EEHV7. After infection and replication occurred in the endothelia, EEHV induced endothelial damage throughout the body and caused diffused hemorrhaging and edema of the internal organs. Subsequently, together with the up-regulation of inflammatory cytokines (so-called “cytokine storm”) by virus-infected cells, EEHV-infection also altered the coagulation system and caused thrombo-emboli in the blood vessels. These complex processes lead to disseminated intravascular coagulopathy, which could further enhance bleeding tendencies in EEHV-HD cases (Fig. 7). Consequently, elephants may die due to hypovolemic shock and/or organ failure. These processes may be initiated and end as rapidly as 24 h after the onset of the first clinical signs of EEHV-HD. Depending upon the EEHV genotypes, the degree of thrombocytopenia, the affected organs, the severity of the vascular lesions and the viral loads differed among EEHV-infected Asian elephants. Nevertheless, most elephants that succumbed and died due to EEHV-HD presented significant hematological signs of thrombocytopenia and systemic coagulative disorder.
Activation of coagulation cascades during inflammation is the result of the stimulation of coagulation synthesis, a decrease in the synthesis of anti-coagulants and the suppression of fibrinolysis26. These complex cascades are initiated when vascular endothelial damage occurs and there is exposure of subendothelial collagen to von Willebrand factors (vWF), a multimeric glycoprotein present in blood plasma, the subendothelial matrix, endothelial cells and platelets11, 27, 28. The binding of vWF to the subendothelial matrix then mediates the adhesion and aggregation of platelets at sites of vascular injury. This is followed by fibrin polymerization and the formation of platelet plugs to cease blood loss29, 30. Since the roles of vascular damage and coagulation have not yet been investigated in EEHV-HD cases, our findings demonstrate that disruption of endothelia resulted in increased expressions of vWF and PECAM-1. The pathomechanisms of hemorrhaging and edematous lesions in EEHV-HD cases were consistent with the outcomes observed for other virus-induced hemorrhagic diseases14. Moreover, our findings also suggest that the up-regulation of pro-inflammatory and inflammatory cytokines, including IL-1β, IL-2, IL-4 and TNF-α, may also be involved in the pathogenesis of acute hemorrhagic diseases as can be seen in the influenza virus or dengue hemorrhagic fever31, 32. Excessive immune/inflammatory reactions (cytokine storm) have been shown to exacerbate the coagulopathy in many viral-infectious diseases32,33,34,35,36. Thus, it can be presumably concluded that diffused endothelial damage and platelet activation result in platelet plugs within the injured vessels or intravascular network. This can lead to thrombocytopenia which is known as disseminated intravascular coagulation (DIC) in the acute hemorrhagic disease caused by EEHV infection37, 38.
DIC is a complex process, that is characterized by abnormal thrombin generation. This can then lead to diffused fibrin formation, especially within microcirculation and thereby the consumption of platelets, fibrinogen, coagulation factors and inhibitors13, 39. DIC plays a major role in the hemorrhaging and edema that occur in several viral hemorrhagic diseases in humans and animals such as the Ebola virus, avian influenza, African swine fever, Marburg disease or severe acute respiratory syndrome (SARS)17, 38, 40, 41. Despite the fact that there is no gold standard for the diagnosis of DIC and no specific biomarkers that can be employed to clearly diagnose DIC in humans42, clinical laboratory diagnosis of DIC in animals can be accomplished when three or more of the following abnormalities are found; (1) the prothrombin time (PT) is 3 or more seconds greater than the control or partial thromboplastin time (PTT) is 5 or more seconds greater than the upper limit of normal; (2) the presence of elevated D-dimer; (3) a decrease in platelet count; (4) an absolute decrease in plasma fibrinogen levels ≥ 25%; and (5) the presence of positive PTAH staining for intravascular fibrin formation43, 44. Due to limitations in the availability of blood samples, PT and PTT tests of EEHV-HD cases were not conducted. Moreover, the plasma fibrinogen count of the acute EEHV-HD cases observed in this study was not significantly different when compared to the EEHV negative cases. However, this outcome could have been due to a severe loss in fluid and protein that occurred from blood circulation. Fatal EEHV-HD cases may result in a total reduction in blood cells and plasma proteins in relation to the fluid volume obtained from blood vessels. The massive fluid loss from the blood vessels may then influence the absolute fibrinogen count in the blood of elephants. Thus, we have suggested that red blood cell counts, PCV or total plasma proteins may not be appropriate hematological parameters for determining the fatality signs of acute EEHV-HD. However, the fact that a reduction in the platelet count, as well as the presence of PTAH positive fibrin thrombi in the blood vessels of EEHV-HD calves in the present study, strongly suggest that DIC occurs as a result of, and is directly involved in, pathogenesis of a bleeding disorder in EEHV-HD calves.
We have hypothesized that thrombocytopenia in EEHV-HD cases is less likely to be caused by platelet destruction or a reduced level of production of the platelets. This conclusion can be explained by the fact that the average platelet count in non-fatal EEHV-infected calves was determined to be within a normal reference value when compared to the EEHV-negative controls. This conclusion was further emphasized by findings that a sudden fall in the platelet count occurred within 24 h prior to the acute death of elephant calves that could have been due to utilization of platelets during primary hemostasis42. In addition, the H&E staining of elephant bone marrow samples in our previous study indicated that there were no differences in the relative number of megakaryocytes in the EEHV-HD and EEHV-negative cases7. The data suggest that thrombocytopenia in EEHV-HD calves is less likely due to a reduction in platelet production. On the other hand, acute onset of thrombocytopenia suggests that it is more likely due to the consumption rather than the destruction of platelets in fatal EEHV-HD cases. More specifically, platelet destruction is found to be predominantly observed in the immune-mediated thrombocytopenia such as drug-induced immune mediated thrombocytopenia and autoimmune diseases45,46,47,48. Collectively and based on this conclusion, therapeutic intervention of acute EEHV-HD cases through the use platelet-rich plasma (PRP) is highly recommended.
The findings of our study suggest that plasma leakage in the EEHV-HD elephant cases was not due to mast cell activation and degranulation. An increase in the degree of plasma leakage from blood circulation is one of the most striking outcomes of several viral hemorrhagic diseases such as Dengue hemorrhagic fever19,20,21. It has been shown that degranulation of mast cells can increase vascular permeability and cause vascular leakage in Dengue hemorrhagic fever patients19,20,21, 49. These effects were evidenced by a relatively low degree or absence of tissue inflammation, endothelial cell edema and perivascular edema50. Activation of mast cells around the blood vessels was observed by an increase in the number and release of chromogenic granules, which can be detected by the toluidine blue stain. The fact that only small amounts of granulated and degranulated mast cells were observed around the medium and small blood vessels of EEHV-HD calves suggests that vascular hyperpermeability in these cases was unlikely caused by the activation of mast cells. On the other hand, it should be noted that the up-regulation of cytokines and inflammatory mediators during virus infection can also cause endothelial contraction and could enhance vascular permeability in in vitro and in vivo experiments51,52,53,54. It remains to be determined if the up-regulation of IL-1β, IL-2, IL-4, IL-8 and TNF-α observed in this study was involved in vascular hyperpermeability. Notably, other tissue factors, such as those associated with nitric oxide, are also known to be cellular mediators that can increase vascular permeability55. Therefore, the role of other cellular mediators in EEHV infection needs to be further investigated.
In conclusion, our present study suggests that DIC did occur in EEHV-HD cases among Asian elephants. Furthermore, DIC together with a disruption of small blood vessels can lead to diffused hemorrhaging of the internal organs. Diffused, severe hemorrhaging and edema of the subcutaneous tissue and internal organs may lead to hypovolemic shock and ultimately lead to fatalities in EEHV-HD calves. The present study also demonstrated that, unlike Dengue hemorrhagic fever, mast cell degranulation is less likely a cause of vascular and protein leakage in EEHV-HD cases. Thus, based on our current understanding of the EEHV pathogenesis, treatment of EEHV-HD cases should be included antiviral drugs, cytokine storm treatment and antithrombotic therapy. Moreover, application of antioxidants, such as vitamin C, is also suggested as a prophylactic support against EEHV-HD. To summarize, the present study has brought attention to the pathogenesis of EEHV coagulopathy and may be useful for further therapeutic intervention in EEHV-infected Asian elephants.
Samples and tissue processing
The profiles of blood analyses that can intensely influence the vascular coagulation system, specifically in the manner of platelet count and plasma protein concentrations, and archived of formalin-fixed, paraffin-embedded (FFPE) tissues or frozen tissues of fatal EEHV-HD, non-fatal EEHV-infected and EEHV-negative cases were obtained from the Veterinary Diagnostic Center, Faculty of Veterinary Medicine, Chiang Mai University, Thailand between the years of 2015 and 2020 (Table 1 and Table S1). The blood of these elephants was obtained at either routine annual health checkups or clinical routine monitoring during the course of EEHV infection. The EEHV-negative samples used in this study were taken from a calf that had been diagnosed as stillbirth and a calf that died due to un-related EEHV infection6, 7. In cases of non-fatal EEHV-infection or fatal EEHV-HD, subjects were further diagnosed to specify the EEHV genotypes using PCR and gene sequencing, as has been previously described4. FFPE samples of EEHV1A-HD (n = 3), EEHV4 (n = 2), EEHV1A/4-HD (n = 1) and EEHV-negative calves (n = 2) were 3 µm-thick cut and processed for further histopathological investigation by being stained with hematoxylin and eosin (H&E) stain4, periodic acid-Schiff (PAS) stain, toluidine blue stain or Mallory's phosphotungstic acid hematoxylin (PTAH) stain. This entire process will be described in greater detail below. Samples subjected to immunohistochemistry were 3 µm-thick and obtained on 3-Aminopropyl-triethoxysilane coated-slides. In addition, frozen tissue samples of the EEHV1A-HD, EEHV4-HD, EEHV1A/4-HD and EEHV-negative cases were subjected to further analysis in order to determine viral loads and the degree of cytokine mRNA expression using quantitative PCR and RT-PCR, as has been previously described6, 56, 57. All experimental animal protocols in this study were consistent with the Guide for the Care and Use of Laboratory Animals (National Institute of Animal Health, WA). The blood sampling protocol that was used for animals in this study was approved of by the Faculty of Veterinary Medicine, Chiang Mai University Animal Care and Use Committee (License number S22/2563).
Periodic acid-Schiff (PAS) staining
To investigate the basement membrane of elephant blood vessels, periodic acid-Schiff (PAS) staining was done according to the method previously described58. Briefly, 3 µm-thick sections were deparaffinized and rehydrated. They were then incubated with a periodic acid solution for 5 min at room temperature (RT). After being washed with tap water, slides were then incubated in Schiff solution for 15 min at RT and then washed again with tap water. Nuclei were visualized with hematoxylin prior to being dehydrated and mounted with a cover glass. The slides were observed and photos were taken using a light microscope.
Toluidine blue staining
To identify mast cells in elephant tissues, toluidine blue stain was used. Briefly, after deparaffinization and rehydration, sections were stained with 0.1% toluidine blue for approximately 15 s and then quickly washed three times with distilled water for 5 min each. They were then incubated with 30% alcohol and dehydrated by sequentially dipping them for approximately 5 s each in 75%, 85%, 95% and 100% alcohol, respectively. Thereafter, sections were dipped in xylene for 5 min, mounted with cover glasses and examined under a light microscope. Intact mast cells showed deep magenta staining, while degranulated mast cells showed purple or magenta granules that extruded adjacent to the mast cells. The intact and degranulated mast cell numbers in each slide (organ) were randomly counted from 10 high power fields, as has been previously described59.
Phosphotungstic acid hematoxylin (PTAH) stain
To examine the fibrin formation within and outside the blood vessels, phosphotungstic acid hematoxylin (PTAH Stain Kit, Abcam, Cambridge, UK) staining was done according to the manufacturer’s instructions. Briefly, FFPE slides were deparaffinized and rehydrated with xylene and a series of graded alcohol solutions. Slides were then incubated with agitation in a warmed zinc chloride solution for 15 min. After being washed with running tap water, slides were further incubated in warmed ferric ammonium sulphate aqueous solution for 2 min. Thereafter, they were rinsed with running tap water for 2 min and incubated with a warmed PTAH solution for 30 min. Differentiations in color were observed in 95% alcohol until the desired stain was obtained. Slides were then dehydrated, mounted with permount and coverslips, and then observed under a light microscope.
Grading of vascular lesions
Grading of the vascular lesions was done by three independent pathologists who were not aware of the sample groups. Vascular lesions were categorized, according to the method previously described60 with slight modifications, where grade 0 = normal finding, grade 1 = mild dilation of small blood vessels with no alteration of blood vessel walls, grade 2 = increased blood volume and strong vasodilation with erythrocyte accumulation, grade 3 = transmural rupture of a small number (up to 50%) of blood vessels with accumulation of the inflammatory cells, grade 4 = complete loss of the basement membrane and endothelial cells of a large number (> 50%) of blood vessels and grade 5 = diffused hemorrhaging of the tissues with or without visible blood vessels. The areas assessed included the endothelia of the capillaries, large, medium and small blood vessels of the heart, kidneys, liver, lungs, spleen, and the small and large intestines of fatal EEHV-HD cases. The results of the analysis were then compared to the EEHV-negative controls.
Immunohistochemistry was performed by employing the avidin–biotin complex (ABC) method as has been described previously6, 61. Briefly, FFPE sections were deparaffinized, rehydrated and then microwaved for 30 min in citrate buffer (pH 6.0). Sections were incubated for 5 min with 3%H2O2 in methanol and then blocked for 1 h at RT with PBS containing 5% normal goat serum and 0.1% Triton X-100. Thereafter, they were incubated for 2 h at RT with primary antibodies. The primary antibodies used in this study included the rabbit anti-platelet endothelial cell adhesion molecules-1 (PECAM-1; 1:400) and rabbit anti-von Willebrand factor (vWF; 1:400, all obtained from Abcam, Cambridge, UK). After being washed, sections were incubated for 45 min at RT with biotinylated secondary antibody (1:200; Vector Laboratories, CA, USA), followed by peroxidise coupled ABC (Thermo Fischer Scientific, Waltham, MA, USA). Antibody binding was visualized using DAB-H2O2 for 5 min at RT followed by being counterstained with hematoxylin. They were then dehydrated, mounted with coverslips and observed under a light microscope. Scoring of immunolabeling positive cells for each antibody in different anatomical regions was done according to the method previously described6.
Quantitative PCR and RT-PCR
To quantify the viral genome copies (vgc) of EEHV in various organs, total DNA of frozen EEHV1A-HD, EEHV4-HD and EEHV1A/4-HD tissues (heart, lungs, liver, spleen, kidney and intestines) were extracted using a commercial DNA extraction kit (NucleoSpin Tissue, Machery-Nagel GmbH, Düren, Germany). Primers of the terminase gene for the identification of EEHV1 and the polymerase gene for the identification of EEHV3/4 were used according to the previous studies3, 57. For the calculation of the number of viral copies, the target genes were amplified from total viral DNA. Conventional PCR cycling was initiated at 98 °C for 1 min followed by 98 °C for 10 s, 50 °C for 20 s, 72 °C for 15 s (35 cycles), and a final extension at 72 °C for 7 min using Phusion High-Fidelity PCR Master Mix (Thermo Scientific, USA). PCR products were then cut and purified from agarose gel using a GeneJET Gel Extraction and DNA Cleanup Micro Kit (Thermo Scientific, USA). The dsDNA concentrations were quantified from UV/Vis spectrophotometer (DU730; Beckman Coulter, USA) and viral copy numbers were determined and calculated as has been previously described56. DNA was resuspended in water and were 10-fold diluted from 1010 to 100 copies in number. Absolute quantification in qPCR was performed under the following conditions: 95 °C for 2 min, 40 cycles of 95 °C for 5 s, 50 °C for 30 s, 72 °C for 30 s, and a final extension step at 72 °C for 10 min using Sensifast SYBR-Hi Rox (Bioline, Luckenwalde, Germany) with a ABI7300 thermocycler (Applied Biosystems, CA, USA). The differences between the threshold cycles (Ct) and Log value of the copy numbers were used to simulate linear regression, which was then used to estimate the viral copy numbers in 100 ng of DNA in each organ.
In order to quantify the expression of pro-inflammatory and inflammatory cytokines between the fatal EEHV-HD and the EEHV-negative control calves, real time PCR (SYBR green selected master mix, Life Technologies, CA, USA) was performed in a total reaction volume of 20 μL. Primers of IL-1β, IL-2, IL-4, IL-8, TNF-α, IFN-γ and GAPDH were used as has been previously described6. PCR conditions were 95 °C for 10 min, followed by 40 cycles of 95 °C for 15 s, 60 °C for 30 s, and 72 °C for 30 s. The Ct of all genes were used to calculate the degree of gene expression using 2−∆∆CT method62 normalized to that of the GAPDH gene and compared to the EEHV-negative controls, as has been previously described6.
Statistical analyses were conducted using GraphPad Prism 5 (GraphPad Inc., La Jolla, CA, USA). Either unpaired t-test or one-way analysis of variance (ANOVA) was performed using mean or median values, followed by Tukey’s post hoc test depending upon the data types. Statistical significance was designated at p ≤ 0.05.
Ling, P. D. et al. Complete genome sequence of elephant endotheliotropic herpesvirus 4, the first example of a GC-rich branch proboscivirus. mSphere 1(3), e00081–15 (2016).
Wilkie, G. S. et al. First fatality associated with elephant endotheliotropic herpesvirus 5 in an Asian elephant: Pathological findings and complete viral genome sequence. Sci. Rep. 4, 6299 (2014).
Richman, L. K. et al. Novel endotheliotropic herpesviruses fatal for Asian and African elephants. Science 283, 1171–1176 (1999).
Kochagul, V. et al. Production of antibody against elephant endotheliotropic herpesvirus (EEHV) unveils tissue tropisms and routes of viral transmission in EEHV-infected Asian elephants. Sci. Rep. 8, 4675 (2018).
Dastjerdi, A., Seilern-Moy, K., Darpel, K., Steinbach, F. & Molenaar, F. Surviving and fatal Elephant Endotheliotropic Herpesvirus-1A infections in juvenile Asian elephants - lessons learned and recommendations on anti-herpesviral therapy. BMC Vet. Res. 12, 178 (2016).
Srivorakul, S. et al. Possible roles of monocytes/macrophages in response to elephant endotheliotropic herpesvirus (EEHV) infections in Asian elephants (Elephas maximus). PLoS ONE 14, e0222158 (2019).
Guntawang, T. et al. In vivo characterization of target cells for acute elephant endotheliotropic herpesvirus (EEHV) infection in Asian elephants (Elephas maximus). Sci Rep 10, 11402 (2020).
Long, S. Y., Latimer, E. M. & Hayward, G. S. Review of elephant endotheliotropic herpesviruses and acute hemorrhagic disease. ILAR J 56, 283–296 (2016).
Chanthick, C., Suttitheptumrong, A., Rawarak, N. & Pattanakitsakul, S. N. Transcytosis Involvement in transport system and endothelial permeability of vascular leakage during dengue virus infection. Viruses 10(2), 69 (2018).
Schnittler, H. J. & Feldmann, H. Viral hemorrhagic fever—A vascular disease?. Thromb. Haemost. 89, 967–972 (2003).
Lenting, P. J., Christophe, O. D. & von Denis, C. V. Willebrand factor biosynthesis, secretion, and clearance: Connecting the far ends. Blood 125, 2019–2028 (2015).
Gaugler, M. H., Vereycken-Holler, V., Squiban, C. & Aigueperse, J. PECAM-1 (CD31) is required for interactions of platelets with endothelial cells after irradiation. J. Thromb. Haemost. 2, 2020–2026 (2004).
Thachil, J. Disseminated intravascular coagulation—New pathophysiological concepts and impact on management. Expert Rev. Hematol. 9, 803–814 (2016).
Gando, S., Levi, M. & Toh, C. H. Disseminated intravascular coagulation. Nat. Rev. Dis. Primers 2, 16037 (2016).
Assinger, A. Platelets and infection—An emerging role of platelets in viral infection. Front. Immunol. 5, 649 (2014).
Zapata, J. C., Cox, D. & Salvato, M. S. The role of platelets in the pathogenesis of viral hemorrhagic fevers. PLoS Negl. Trop. Dis. 8, e2858 (2014).
Levi, M., Schultz, M. & van der Poll, T. Disseminated intravascular coagulation in infectious disease. Semin. Thromb. Hemost. 36, 367–377 (2010).
Flaujac, C., Boukour, S. & Cramer-Borde, E. Platelets and viruses: An ambivalent relationship. Cell Mol. Life Sci. 67, 545–556 (2010).
Brown, M. G. et al. Dengue virus infection of mast cells triggers endothelial cell activation. J. Virol. 85, 1145–1150 (2011).
Malavige, G. N. & Ogg, G. S. Pathogenesis of vascular leak in dengue virus infection. Immunology 151, 261–269 (2017).
Londono-Renteria, B., Marinez-Angarita, J. C., Troupin, A. & Colpitts, T. M. Role of mast cells in dengue virus pathogenesis. DNA Cell Biol. 36, 423–427 (2017).
Fowler, M. E. & Mikota, S. K. (2006). Hemolymphatic system. in Biology, Medicine, and Surgery of Elephants.
Jolly, S., Detilleux, J. & Desmecht, D. Extensive mast cell degranulation in bovine respiratory syncytial virus-associated paroxystic respiratory distress syndrome. Vet. Immunol. Immunopathol. 97, 125–136 (2004).
Rabelo, K. et al. Zika virus infects human placental mast cells and the HMC-1 cell line, and triggers degranulation, cytokine release and ultrastructural changes. Cells 9(4), 975 (2020).
Liu, L. & Shi, G. P. CD31: Beyond a marker for endothelial cells. Cardiovasc. Res. 94, 3–5 (2012).
Lipinski, S. et al. Coagulation and inflammation. Molecular insights and diagnostic implications. Hamostaseologie 31, 94–104 (2011).
Sadler, J. E. Biochemistry and genetics of von Willebrand factor. Annu. Rev. Biochem. 67, 395–424 (1998).
Leebeek, F. W. & Von Eikenboom, J. C. Willebrand’s disease. N. Engl. J. Med. 375, 2067–2080 (2016).
Nieswandt, B., Pleines, I. & Bender, M. Platelet adhesion and activation mechanisms in arterial thrombosis and ischaemic stroke. J. Thromb. Haemost. 9(Suppl 1), 92–104 (2011).
Ruggeri, Z. M. Role of von Willebrand factor in platelet thrombus formation. Ann. Med. 32(Suppl 1), 2–9 (2000).
Wang, S. et al. Influenza virus-cytokine-protease cycle in the pathogenesis of vascular hyperpermeability in severe influenza. J. Infect. Dis. 202, 991–1001 (2010).
Mangione, J. N. et al. The association of cytokines with severe dengue in children. Trop. Med. Health 42, 137–144 (2014).
McGonagle, D., Sharif, K., O’Regan, A. & Bridgewood, C. The role of cytokines including interleukin-6 in COVID-19 induced pneumonia and macrophage activation syndrome-like disease. Autoimmun. Rev. 19, 102537 (2020).
Belen-Apak, F. B. & Sarialioglu, F. Pulmonary intravascular coagulation in COVID-19: Possible pathogenesis and recommendations on anticoagulant/thrombolytic therapy. J. Thromb. Thrombolysis 50, 278–280 (2020).
Gu, S. X. et al. Thrombocytopathy and endotheliopathy: Crucial contributors to COVID-19 thromboinflammation. Nat. Rev. Cardiol. 18, 194–209 (2021).
Martina, B. E. Dengue pathogenesis: A disease driven by the host response. Sci. Prog. 97, 197–214 (2014).
Davis, R. P., Miller-Dorey, S. & Jenne, C. N. Platelets and coagulation in infection. Clin. Transl. Immunol. 5, e89 (2016).
Goeijenbier, M. et al. Review: Viral infections and mechanisms of thrombosis and bleeding. J. Med. Virol. 84, 1680–1696 (2012).
Blome, S., Meindl-Bohmer, A., Nowak, G. & Moennig, V. Disseminated intravascular coagulation does not play a major role in the pathogenesis of classical swine fever. Vet. Microbiol. 162, 360–368 (2013).
Takada, A. & Kawaoka, Y. The pathogenesis of Ebola hemorrhagic fever. Trends Microbiol. 9, 506–511 (2001).
Vallee, I., Tait, S. W. & Powell, P. P. African swine fever virus infection of porcine aortic endothelial cells leads to inhibition of inflammatory responses, activation of the thrombotic state, and apoptosis. J. Virol. 75, 10372–10382 (2001).
Wada, H. et al. Differences and similarities between disseminated intravascular coagulation and thrombotic microangiopathy. Thromb. J. 16, 14 (2018).
Wang, B., Wu, S., Wang, T., Ma, Z. & Liu, K. Bone marrow-derived mesenchymal stem cells-mediated protection against organ dysfunction in disseminated intravascular coagulation is associated with peripheral immune responses. J. Cell Biochem. 118, 3184–3192 (2017).
Kessler, C. M., Tang, Z., Jacobs, H. M. & Szymanski, L. M. The suprapharmacologic dosing of antithrombin concentrate for Staphylococcus aureus-induced disseminated intravascular coagulation in guinea pigs: Substantial reduction in mortality and morbidity. Blood 89, 4393–4401 (1997).
Sim, D. W., Yu, J. E., Jeong, J. & Koh, Y. I. Ciprofloxacin-induced immune-mediated thrombocytopenia: No cross-reactivity with gemifloxacin. J. Clin. Pharm. Ther. 43, 134–136 (2018).
Shih, A. W., Lam, A. S. & Warkentin, T. E. Levofloxacin-induced acute immune-mediated thrombocytopenia of rapid-onset. J. Pharm. Pract. 31, 234–237 (2018).
Lo, E. & Deane, S. Diagnosis and classification of immune-mediated thrombocytopenia. Autoimmun. Rev. 13, 577–583 (2014).
Orcutt, E. S., Lee, J. A. & Bianco, D. Immune-mediated hemolytic anemia and severe thrombocytopenia in dogs: 12 cases (2001–2008). J. Vet. Emerg. Crit. Care (San Antonio) 20, 338–345 (2010).
Avirutnan, P. & Matangkasombut, P. Unmasking the role of mast cells in dengue. Elife 2, e00767 (2013).
Srikiatkhachorn, A., Mathew, A. & Rothman, A. L. Immune-mediated cytokine storm and its role in severe dengue. Semin. Immunopathol. 39, 563–574 (2017).
Feldmann, H. et al. Filovirus-induced endothelial leakage triggered by infected monocytes/macrophages. J. Virol. 70, 2208–2214 (1996).
Sundstrom, J. B. et al. Hantavirus infection induces the expression of RANTES and IP-10 without causing increased permeability in human lung microvascular endothelial cells. J. Virol. 75, 6070–6085 (2001).
Wahl-Jensen, V. M. et al. Effects of Ebola virus glycoproteins on endothelial cell activation and barrier function. J. Virol. 79, 10442–10450 (2005).
Connolly-Andersen, A. M. et al. Crimean-Congo hemorrhagic fever virus activates endothelial cells. J. Virol. 85, 7766–7774 (2011).
Yan, Z. Q., Yokota, T., Zhang, W. & Hansson, G. K. Expression of inducible nitric oxide synthase inhibits platelet adhesion and restores blood flow in the injured artery. Circ. Res. 79, 38–44 (1996).
Stanton, J. J. et al. Detection of pathogenic elephant endotheliotropic herpesvirus in routine trunk washes from healthy adult Asian elephants (Elephas maximus) by use of a real-time quantitative polymerase chain reaction assay. Am. J. Vet. Res. 71, 925–933 (2010).
Latimer, E., Zong, J. C., Heaggans, S. Y., Richman, L. K. & Hayward, G. S. Detection and evaluation of novel herpesviruses in routine and pathological samples from Asian and African elephants: identification of two new probosciviruses (EEHV5 and EEHV6) and two new gammaherpesviruses (EGHV3B and EGHV5). Vet. Microbiol. 147, 28–41 (2011).
Tiwananthagorn, S., Srivorakul, S., Khochakul, V. & Pringproa, K. Biliary cystadenoma associated with Opisthorchis viverrini infection in a domestic cat (Felis catus). Vet. Parasitol. 258, 138–141 (2018).
Li, W. W. et al. Substance P signaling controls mast cell activation, degranulation, and nociceptive sensitization in a rat fracture model of complex regional pain syndrome. Anesthesiology 116, 882–895 (2012).
Caloglu, M., Caloglu, V. Y., Yalta, T., Yalcin, O. & Uzal, C. The histopathological comparison of l-carnitine with amifostine for protective efficacy on radiation-induced acute small intestinal toxicity. J. Cancer Res. Ther. 8, 260–265 (2012).
Pringproa, K. et al. Histopathological and Immunohistochemical Characterization of Spontaneous Uterine Leiomyomas in Two Captive Asian Elephants. Thai Journal of Veterinary Medicine 45, 289–294 (2015).
Lehmann, U. & Kreipe, H. Real-time PCR analysis of DNA and RNA extracted from formalin-fixed and paraffin-embedded biopsies. Methods 25, 409–418 (2001).
This project was partially supported by the Center of Excellence in Elephant and Wildlife Research, Chiang Mai University, Thailand and by the TRF Research Career Development Grant, Thailand Research Fund (Grant number RSA6280018). Additionally, T. Guntawang received financial support through a grant from the Thailand Research Fund (Grant number PHD61I0012) and T. Sittisak received financial support through the Thailand Research Fund (Grant number PHD/0113/2561).
The authors declare no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Guntawang, T., Sittisak, T., Kochagul, V. et al. Pathogenesis of hemorrhagic disease caused by elephant endotheliotropic herpesvirus (EEHV) in Asian elephants (Elephas maximus). Sci Rep 11, 12998 (2021). https://doi.org/10.1038/s41598-021-92393-8